Product Information
SULINDAC 200 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.2321 per EA under NDC 00904733560. Its NADAC has been published 132 times since Jan 24, 2024.
FDA first approved this application on Apr 17, 1991. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the sulindac market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904733560
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
SULINDACApproval Type
Generic (ANDA)
FDA Application
ANDA072051FDA Approved
4/17/1991
TE Code
AB
On Market Since
7/27/2023
Pharmacological Classes
Price Statistics
The NADAC for SULINDAC 200 MG TABLET has been published 132 times since Jan 24, 2024, and over the history we have for it it has risen 7.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2321 per EA |
|---|---|
| All-time high | $0.2398 (Jun 11, 2025) |
| All-time low | $0.1710 (Jul 17, 2024) |
| 52-week high | $0.2384 |
| 52-week low | $0.2197 |
| Median price | $0.2238 |
| Average price | $0.2158 |
| Largest weekly change | -24.8% (Jul 17, 2024) |
| Weeks tracked | 132 |
| Tracking since | Jan 24, 2024 |
1W
N/A
1M
0.0%
3M
-2.7%
6M
+5.0%
1Y
+5.6%
3Y
N/A
5Y
N/A
All
+7.5%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SULINDAC 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SULINDAC 200 MG TABLET, manufactured by Major Pharmaceuticals, is $0.2321 per EA (NDC 00904733560), effective Jul 29, 2026.
How has the price of SULINDAC 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for SULINDAC 200 MG TABLET has risen 7.5%. It has been tracked across 132 weekly CMS publications since Jan 24, 2024.
What are the highest and lowest recorded NADAC prices for SULINDAC 200 MG TABLET?
Since Jan 24, 2024, the NADAC for SULINDAC 200 MG TABLET has ranged from a low of $0.1710 (Jul 17, 2024) to a high of $0.2398 (Jun 11, 2025), with a median of $0.2238 per EA.
Are there cheaper alternatives to SULINDAC 200 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SULINDAC 200 MG TABLET, is $0.2270 per EA — about 2% below SULINDAC 200 MG TABLET.
Who manufactures SULINDAC 200 MG TABLET?
SULINDAC 200 MG TABLET (NDC 00904733560) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.